NCT04629911 is a NA clinical trial of THRIVE in Gastric Distention, sponsored by Ajou University School of Medicine.

Who is sponsoring NCT04629911?

NCT04629911 is sponsored by Ajou University School of Medicine.

What drugs are being tested in NCT04629911?

Interventions in NCT04629911: THRIVE.

What condition does NCT04629911 study?

NCT04629911 studies Gastric Distention.

Is NCT04629911 still recruiting?

NCT04629911 is currently completed. Last updated 5 January 2022.

Last reviewed 2022-01-05 · How we verify

NCT04629911

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High Flow Nasal Oxygenation and Gastric Insufflation in Anesthetized Patients

Completed NA Last updated 5 January 2022

What this trial tests

NA trial testing THRIVE in Gastric Distention in 45 participants. Completed in 24 August 2021.

Timeline

23 November 2020

Primary endpoint
24 August 2021

24 August 2021

Quick facts

Lead sponsor	Ajou University School of Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	45
Start date	23 November 2020
Primary completion	24 August 2021
Estimated completion	24 August 2021
Sites	1 location across South Korea

Drugs / interventions tested

THRIVE

Conditions studied

Gastric Distention — all drugs for Gastric Distention →

Sponsor

Ajou University School of Medicine

Who can join

Adults 19 to 80, any sex, with Gastric Distention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transnasal humidified rapid-insufflation ventilatory exchange(THRIVE), or also termed high flow nasal oxygenation (HFNO) is a method of supplying heated, humidified high concentrations of oxygen via nasal cavity. The purpose of this study is to investigate the effect of HFNO on gastric insufflation in paralyzed anesthetized patients undergoing laryngologic surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of High-Flow Nasal Oxygenation on Gastric Insufflation in Patients Undergoing Laryngeal Microsurgery under Tubeless General Anesthesia with Neuromuscular Blockade.
Chang MY, Kwak HJ, Kim JY, Park JY, et al · · 2023 · cited 6× · PMID 36902586 · DOI 10.3390/jcm12051800

Verify or expand the search:

Other trials of THRIVE

Trials testing the same drug.

NCT06489522 — Parenting Intervention for Mothers With Substance Use Disorder · NA · completed
NCT06581588 — Apneic Oxygenation by Transnasal Humidified Rapid Insufflation Ventilator Exchange Obstructive Sleep Apnea Patients · NA · completed
NCT06139874 — Thrive Intervention in Schools · NA · enrolling by invitation
NCT05535192 — TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients · NA · recruiting
NCT05400642 — Randomized Controlled Trial:High-flow Oxygen Therapy and Tracheal Intubation for Laryngeal Microsurgery · NA · unknown

Other Ajou University School of Medicine trials

Trials by the same sponsor.

NCT07101380 — Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients · NA · recruiting
NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
NCT06964217 — Immediate Fracture Risk After Antihypertensive Drug Initiation · not yet recruiting
NCT05751603 — Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex · NA · not yet recruiting
NCT07479160 — Heart to Heart Web-based Communication Program for Heart Failure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04629911 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ajou University School of Medicine
Last refreshed: 5 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04629911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing